SOPHIA GENETICS SA
SOPHNASDAQ🏆 #2665 by market capEarnings Nov 3 · PreUS Equity
$7.85▲ $0.33 (+4.39%)
Pre-market · at closeTrack SOPH
Get earnings, price moves & breaking news on Telegram
24h▲ 4.4%
7d▲ 11.5%
14d▲ 7.5%
30d▼ 5.4%
ytd▲ 67.4%
1y▲ 72.1%
🏦Market Cap
$668M
Small Cap
📈Revenue Growth (YoY)
23.6%
Healthy
📊Gross Margin
66.6%
High
💵FCF Margin
—
⚖️P/S Ratio
7.4x
Fair
Otter Score
80
Strong
Trading Snapshot
- Day Range
- $7.63 – $7.85
- 52-Week Range
- $3.83 – $8.98
- Volume (shares)
- 21,511
- Avg Volume (shares)
- —
- Shares Outstanding
- 85.1M
- Next Earnings
- 2026-11-03
Fundamentals Snapshot
- Annual Revenue
- $77M
- Last Q Revenue
- $23M
- P/E Ratio
- —
- P/S Ratio
- 7.4x
- EPS (TTM)
- $-1.15
- Dividend Yield
- —
- Dilution (1yr)
- +3.5%
SOPHIA GENETICS SA
SOPHFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$77M▲ +18.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
61.9%▼ −8.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$71M▲ +6.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$39M▼ −24.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
68.2M▲ +3.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$7M▼ −$43M YoY
StockOtter · stockotter.spaceAbout SOPHIA GENETICS SA
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Strong
80/100
Analyst Ratings
ⓘConsensus
Buy
11 analysts
Strong Buy4
Buy6
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.